Rachael Anforth

1.1k total citations
18 papers, 792 citations indexed

About

Rachael Anforth is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Rachael Anforth has authored 18 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 16 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Rachael Anforth's work include Melanoma and MAPK Pathways (16 papers), Cutaneous Melanoma Detection and Management (15 papers) and Colorectal Cancer Treatments and Studies (6 papers). Rachael Anforth is often cited by papers focused on Melanoma and MAPK Pathways (16 papers), Cutaneous Melanoma Detection and Management (15 papers) and Colorectal Cancer Treatments and Studies (6 papers). Rachael Anforth collaborates with scholars based in Australia, United States and Chile. Rachael Anforth's co-authors include Pablo Fernández‐Peñas, Georgina V. Long, Giuliana Carlos, Arthur Clements, Shaun Chou, Richard Kefford, Tatiana Cristina Moraes Pinto Blumetti, Richard A. Scolyer, Alexander M. Menzies and R. Sharma and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Journal of the American Academy of Dermatology.

In The Last Decade

Rachael Anforth

18 papers receiving 782 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachael Anforth Australia 13 554 548 147 119 102 18 792
Christina Mateus France 6 222 0.4× 287 0.5× 149 1.0× 85 0.7× 41 0.4× 11 524
Christine Longvert France 12 353 0.6× 233 0.4× 42 0.3× 71 0.6× 20 0.2× 34 525
Jian‐Zhong Qin United States 8 224 0.4× 479 0.9× 27 0.2× 44 0.4× 83 0.8× 8 641
Rebeca Manso Spain 13 217 0.4× 342 0.6× 67 0.5× 39 0.3× 162 1.6× 38 565
Philip Eliades United States 9 245 0.4× 193 0.4× 67 0.5× 50 0.4× 36 0.4× 12 481
Pietro Gangemi Italy 12 164 0.3× 241 0.4× 22 0.1× 39 0.3× 44 0.4× 15 513
Shanta Chawla United States 7 290 0.5× 330 0.6× 173 1.2× 28 0.2× 336 3.3× 15 702
P. Buhl-Jensen United Kingdom 10 202 0.4× 467 0.9× 31 0.2× 24 0.2× 56 0.5× 13 564
Grazia Palomba Italy 17 229 0.4× 347 0.6× 41 0.3× 35 0.3× 98 1.0× 41 660
Hong Y. Wang United States 8 196 0.4× 313 0.6× 46 0.3× 34 0.3× 139 1.4× 9 551

Countries citing papers authored by Rachael Anforth

Since Specialization
Citations

This map shows the geographic impact of Rachael Anforth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachael Anforth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachael Anforth more than expected).

Fields of papers citing papers by Rachael Anforth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachael Anforth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachael Anforth. The network helps show where Rachael Anforth may publish in the future.

Co-authorship network of co-authors of Rachael Anforth

This figure shows the co-authorship network connecting the top 25 collaborators of Rachael Anforth. A scholar is included among the top collaborators of Rachael Anforth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachael Anforth. Rachael Anforth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pyne, David B., et al.. (2024). Investigating the impact of exercise on T and NK cells in skin cancer: a systematic review.. PubMed. 30. 14–25. 1 indexed citations
2.
Zhao, Cathy, Shelley Ji Eun Hwang, Rachael Anforth, et al.. (2018). Incidence of Basal Cell Carcinoma and Squamous Cell Carcinoma in Patients on Antiprogrammed Cell Death-1 Therapy for Metastatic Melanoma. Journal of Immunotherapy. 41(7). 343–349. 6 indexed citations
3.
Zhao, Cathy, Shelley Ji Eun Hwang, Deepal Wakade, et al.. (2017). Melanocytic lesion evolution patterns with targeted therapies and immunotherapies for advanced metastatic melanoma: An observational study. Australasian Journal of Dermatology. 58(4). 292–298. 7 indexed citations
4.
Hwang, Shelley Ji Eun, Rachael Anforth, Giuliana Carlos, & Pablo Fernández‐Peñas. (2016). Cutaneous Adverse Events of New Anti-melanoma Therapies: Classification and Management. Actas Dermo-Sifiliográficas. 108(1). 6–16. 19 indexed citations
5.
Anforth, Rachael, Alexander M. Menzies, Karen Byth, et al.. (2015). Factors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapy. Journal of the American Academy of Dermatology. 72(5). 809–815.e1. 33 indexed citations
6.
Carlos, Giuliana, Rachael Anforth, Shaun Chou, Arthur Clements, & Pablo Fernández‐Peñas. (2015). A case of bullous pemphigoid in a patient with metastatic melanoma treated with pembrolizumab. Melanoma Research. 25(3). 265–268. 97 indexed citations
7.
Carlos, Giuliana, Rachael Anforth, Arthur Clements, et al.. (2015). Cutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors for Metastatic Melanoma. JAMA Dermatology. 151(10). 1103–1103. 107 indexed citations
8.
Anforth, Rachael, Giuliana Carlos, Noemí Eirís, Arthur Clements, & Pablo Fernández‐Peñas. (2015). Tinea hidden by a vemurafenib‐induced phototoxic reaction in a patient with metastatic melanoma taking dexamethasone. The Medical Journal of Australia. 203(1). 41–42. 2 indexed citations
9.
Uribe, Pablo, Rachael Anforth, Richard Kefford, & Pablo Fernández‐Peñas. (2014). Acneiform eruption in a patient with metastatic melanoma after ceasing combination dabrafenib/trametinib therapy. Melanoma Research. 24(5). 501–503. 7 indexed citations
10.
Choy, Bonita, Shaun Chou, Rachael Anforth, & Pablo Fernández‐Peñas. (2014). Panniculitis in Patients Treated With BRAF Inhibitors. American Journal of Dermatopathology. 36(6). 493–497. 35 indexed citations
11.
Anforth, Rachael, Giuliana Carlos, Richard A. Scolyer, Shaun Chou, & Pablo Fernández‐Peñas. (2014). Eruptive naevi in a patient treated with LGX818 for BRAF mutant metastatic melanoma. Melanoma Research. 25(1). 91–94. 20 indexed citations
12.
Anforth, Rachael, Giuliana Carlos, Arthur Clements, Richard Kefford, & Pablo Fernández‐Peñas. (2014). Cutaneous adverse events in patients treated with BRAF inhibitor-based therapies for metastatic melanoma for longer than 52 weeks. British Journal of Dermatology. 172(1). 239–243. 33 indexed citations
13.
Anforth, Rachael, Michael Liu, Bao N. Nguyen, et al.. (2013). Acneiform eruptions: A common cutaneous toxicity of the MEK inhibitor trametinib. Australasian Journal of Dermatology. 55(4). 250–254. 63 indexed citations
14.
Anforth, Rachael, Tatiana Cristina Moraes Pinto Blumetti, Arthur Clements, et al.. (2013). Systemic retinoids for the chemoprevention of cutaneous squamous cell carcinoma and verrucal keratosis in a cohort of patients on BRAF inhibitors. British Journal of Dermatology. 169(6). 1310–1313. 31 indexed citations
15.
Anforth, Rachael, Pablo Fernández‐Peñas, & Georgina V. Long. (2012). Cutaneous toxicities of RAF inhibitors. The Lancet Oncology. 14(1). e11–e18. 131 indexed citations
16.
Anforth, Rachael, Tatiana Cristina Moraes Pinto Blumetti, Richard Kefford, et al.. (2012). Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma. British Journal of Dermatology. 167(5). 1153–1160. 131 indexed citations
17.
Anforth, Rachael, Varsha Tembe, Tatiana Cristina Moraes Pinto Blumetti, & Pablo Fernández‐Peñas. (2012). Mutational analysis of cutaneous squamous cell carcinomas and verrucal keratosis in patients taking BRAF inhibitors. Pigment Cell & Melanoma Research. 25(5). 569–572. 39 indexed citations
18.
Anforth, Rachael, Tatiana Cristina Moraes Pinto Blumetti, Azura Mohd Affandi, & Pablo Fernández‐Peñas. (2012). Systemic Retinoid Therapy for Chemoprevention of Nonmelanoma Skin Cancer in a Patient Treated With Vemurafenib. Journal of Clinical Oncology. 30(19). e165–e167. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christina Mateus Breakdown of academic impact, for papers by Christine Longvert Breakdown of academic impact, for papers by Jian‐Zhong Qin Breakdown of academic impact, for papers by Rebeca Manso Breakdown of academic impact, for papers by Philip Eliades Breakdown of academic impact, for papers by Pietro Gangemi Breakdown of academic impact, for papers by Shanta Chawla Breakdown of academic impact, for papers by P. Buhl-Jensen Breakdown of academic impact, for papers by Grazia Palomba Breakdown of academic impact, for papers by Hong Y. Wang
Rankless by CCL
2026